BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: López-Hernández A, Pérez-Escuredo J, Vivanco B, García-Inclán C, Potes-Ares S, Cabal VN, Riobello C, Costales M, López F, Llorente JL, Hermsen MA. Genomic profiling of intestinal-type sinonasal adenocarcinoma reveals subgroups of patients with distinct clinical outcomes. Head Neck 2018;40:259-73. [PMID: 28963820 DOI: 10.1002/hed.24941] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Taverna C, Agaimy A, Franchi A. Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and Opportunities. Cancers 2022;14:1463. [DOI: 10.3390/cancers14061463] [Reference Citation Analysis]
2 Re M, Tomasetti M, Monaco F, Amati M, Rubini C, Sollini G, Bajraktari A, Gioacchini FM, Santarelli L, Pasquini E. MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma. Head Neck 2021. [PMID: 34647653 DOI: 10.1002/hed.26894] [Reference Citation Analysis]
3 Lopez DC, Wadley AE, London NR Jr. Emerging concepts in sinonasal tumor research. Curr Opin Otolaryngol Head Neck Surg 2022;30:33-9. [PMID: 34958321 DOI: 10.1097/MOO.0000000000000776] [Reference Citation Analysis]
4 Sánchez-Fernández P, Riobello C, Costales M, Vivanco B, Cabal VN, García-Marín R, Suárez-Fernández L, López F, Cabanillas R, Hermsen MA, Llorente JL. Next-generation sequencing for identification of actionable gene mutations in intestinal-type sinonasal adenocarcinoma. Sci Rep 2021;11:2247. [PMID: 33500480 DOI: 10.1038/s41598-020-80242-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hermsen MA, Riobello C, García-Marín R, Cabal VN, Suárez-Fernández L, López F, Llorente JL. Translational genomics of sinonasal cancers. Semin Cancer Biol 2020;61:101-9. [PMID: 31560943 DOI: 10.1016/j.semcancer.2019.09.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
6 Riobello C, Sánchez-Fernández P, Cabal VN, García-Marín R, Suárez-Fernández L, Vivanco B, Blanco-Lorenzo V, Álvarez Marcos C, López F, Llorente JL, Hermsen MA. Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma. Cancers (Basel) 2021;13:5022. [PMID: 34638506 DOI: 10.3390/cancers13195022] [Reference Citation Analysis]
7 Ferrari M, Bossi P, Mattavelli D, Ardighieri L, Nicolai P. Management of sinonasal adenocarcinomas with anterior skull base extension. J Neurooncol 2020;150:405-17. [PMID: 31897925 DOI: 10.1007/s11060-019-03385-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Maffeis V, Cappellesso R, Zanon A, Cazzador D, Emanuelli E, Martini A, Fassina A. HER2 status in sinonasal intestinal-type adenocarcinoma. Pathol Res Pract 2019;215:152432. [PMID: 31047725 DOI: 10.1016/j.prp.2019.04.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cabezas-Camarero S, de la Orden García V, García-Barberán V, Mediero-Valeros B, Subhi-Issa AI, Llovet García P, Bando-Polaino I, Merino Menéndez S, Pérez-Segura P, Díaz-Rubio E. Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy. Oncologist 2019;24:293-300. [PMID: 30602616 DOI: 10.1634/theoncologist.2018-0387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lechner M, Liu J, Lund VJ. Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside. Curr Oncol Rep 2020;22:106. [PMID: 32725435 DOI: 10.1007/s11912-020-00947-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]